Study of Resilience and Loneliness in Youth (18 - 25 Years Old) During the COVID-19 Pandemic Lock-down Measures.

Sponsor
Erasme University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04371250
Collaborator
Université Libre de Bruxelles (Other), King Baudouin Foundation (Other)
800
1
8
99.8

Study Details

Study Description

Brief Summary

The outbreak linked to SARS-CoV-2 pandemic resulted in lock-down measures in almost all European countries.

This online survey assesses these measures implications on Mental Health in emerging adults.

The questionnaires evaluate two psychometric variables (Resilience and Loneliness) and Mental Health status (mental health professional help-seeking, use of psychotropic drugs, or possible diagnosis) before and during Lock-down Measures.

At least 600 healthy participants aged form 18 to 25 years old will be attended to fill the survey during the SARS-CoV2 Pandemic Lock-down Measures.

Condition or Disease Intervention/Treatment Phase
  • Other: Survey and Questionnaire

Study Design

Study Type:
Observational
Actual Enrollment :
800 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Mental Health Implications During and After the COVID-19 Pandemic Lock-down Measures in Youth (18 - 25 Years Old) in French-Speaking Belgium and Italy: Resilience and Loneliness Evaluation.
Actual Study Start Date :
Apr 30, 2020
Actual Primary Completion Date :
May 31, 2020
Actual Study Completion Date :
Dec 30, 2020

Arms and Interventions

Arm Intervention/Treatment
Youth

Assessed group

Other: Survey and Questionnaire
Resilience and Loneliness questionnaires

Outcome Measures

Primary Outcome Measures

  1. Self-rated measure of Resilience [Up to 1 week after the end of the lock-down measures]

    Measured with the Resilience Scale for Adults (RSA).

  2. Self-rated measure of Loneliness [Up to 1 week after the end of the lock-down measures]

    Measured with the UCLA (University of California, Los Angeles) Loneliness Scale.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 25 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • French-speaking or Italian-speaking

  • Subjects who accepted to participated to the online survey

  • Inhabitants of a European country where SARS-CoV2 Pandemic Lock-down Measures are underway

  • Survey filling date up to one week after the end of Lock-down Measures in the Country of residence

Exclusion Criteria:
  • Incomplete surveys

Contacts and Locations

Locations

Site City State Country Postal Code
1 Erasme University Hospital Brussels Belgium 1070

Sponsors and Collaborators

  • Erasme University Hospital
  • Université Libre de Bruxelles
  • King Baudouin Foundation

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Erasme University Hospital
ClinicalTrials.gov Identifier:
NCT04371250
Other Study ID Numbers:
  • SRB2020_158
First Posted:
May 1, 2020
Last Update Posted:
Feb 9, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Erasme University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 9, 2022